Antiretroviral therapy in the private sector of Nairobi, Kenya: a review of the experience of five physicians

被引：16

作者：

Macharia, DK ^{[1
]}

Chang, LW

Lule, G

Owili, DM

Tesfaledet, G

Patel, S

Silverstein, DM

Ng'ang'a, L

Bush, T

De Cock, KM

Weidle, PJ

机构：

[1] Ctr Dis Control & Prevent, Nairobi, Kenya

[2] Emory Univ, Sch Med, Atlanta, GA USA

[3] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA

[4] MP Shah Hosp, Nairobi, Kenya

[5] CDC, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA

来源：

AIDS | 2003年 / 17卷 / 06期

关键词：

D O I：

10.1097/00002030-200304110-00028

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：938 / 940

页数：3

共 9 条

[1] Public health - HIV/AIDS treatment for millions [J].

Binswanger, HP .

SCIENCE, 2001, 292 (5515) :221-+

[2]

*CDCP, 2001, MMWR-MORBID MORTAL W, V47, P1

[3] The Senegalese government's highly active antiretroviral therapy initiative:: an 18-month follow-up study [J].

Laurent, C ;

Diakhaté, N ;

Gueye, NFN ;

Touré, MA ;

Sow, PS ;

Faye, MA ;

Gueye, M ;

Lanièce, I ;

Kane, CT ;

Liégeois, F ;

Vergne, L ;

Mboup, S ;

Badiane, S ;

Ndoye, I ;

Delaporte, E .

AIDS, 2002, 16 (10) :1363-1370

[4] Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions [J].

Lucas, GM ;

Chaisson, RE ;

Moore, RD .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (02) :81-+

[5] A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients - The INCAS trial [J].

Montaner, JSG ;

Reiss, P ;

Cooper, D ;

Vella, S ;

Harris, M ;

Conway, B ;

Wainberg, MA ;

Smith, D ;

Robinson, P ;

Hall, D ;

Myers, M ;

Lange, JMA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (12) :930-937

[6] Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511) [J].

Saag, MS ;

Tebas, P ;

Sension, M ;

Conant, M ;

Myers, R ;

Chapman, SK ;

Anderson, R ;

Clendeninn, N .

AIDS, 2001, 15 (15) :1971-1978

[7] Overcoming challenges to the implementation of antiretroviral therapy in Kenya [J].

Taegtmeyer, M ;

Chebet, K .

LANCET INFECTIOUS DISEASES, 2002, 2 (01) :51-53

[8]

*UNAIDS WHO WORK G, 2002, EP FACT SHEET HIV AI

[9] Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance [J].

Weidle, PJ ;

Malamba, S ;

Mwebaze, R ;

Sozi, C ;

Rukundo, G ;

Downing, R ;

Hanson, D ;

Ochola, D ;

Mugyenyi, P ;

Mermin, J ;

Samb, B ;

Lackritz, E .

LANCET, 2002, 360 (9326) :34-40

← 1 →